INS and Hyperglycemia: Heparin reduces the binding of insulin to its receptor by interacting with insulin and inhibits insulin-mediated activation of the PI3K/Akt pathway in skeletal muscle, resulting in impaired glucose uptake and hyperglycemia [173].